Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis.
Hasan MushahidSyeda Ayesha ShahSyed Husain FarhanMuhammad Hamza ShujaKyle BalasingamAsad Ali SiddiquiIshaque HameedKamran AkramShayan MushahidMuhammad Shariq UsmanPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
Overall, our findings suggest that bivalirudin may be a more efficacious intervention than heparin for reducing certain adverse events in patients with STEMI undergoing primary PCI.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- coronary artery disease
- coronary artery bypass grafting
- randomized controlled trial
- atrial fibrillation
- coronary artery bypass
- venous thromboembolism
- growth factor
- heart failure
- left ventricular